Home / Companies / Jiangsu Hengrui Pharmaceuticals Co., Ltd. / 16 Apr 2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd.: meeting of 16 Apr 2026
Votes reported on Form N-PX, item by item
71 Form N-PX filers reported votes at the Jiangsu Hengrui Pharmaceuticals Co., Ltd. meeting of 16 Apr 2026. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
4 nominees; 78.6% of reported votes for; 44 filers withheld from or voted against at least one nominee.
551 vote records from 71 filers. 1 of the 71 filers that marked the item either way voted against management.
DIRECTOR ELECTIONSSecurity holder
Director elections (nominees put forward by security holders)
6 nominees; 93.5% of reported votes for; 9 filers withheld from or voted against at least one nominee.
504 vote records from 54 filers. 3 of the 54 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
105 vote records from 71 filers. 44 of the 71 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
210 vote records from 71 filers. 0 of the 71 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
212 vote records from 71 filers. 0 of the 71 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
609 vote records from 71 filers. 0 of the 71 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
28 vote records from 5 filers. 0 of the 5 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Directors | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | Against * |
| BlackRock and iShares | For | No report | Against * |
| Fidelity | For | Against * | For |
| Dimensional | Split or no vote | For | Against * |
| State Street and SPDR | Split or no vote | For | Against * |
| American Century | Split or no vote | For | Against * |
| Franklin Templeton | Split or no vote | For | Against * |
| Equitable | For | For | For |
| Charles Schwab | For | No report | For |
| Nuveen and TIAA | For | For | Against * |
| John Hancock and Manulife | For | No report | Against * |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For |
| Goldman Sachs | Split or no vote | For | Against * |
| WisdomTree | Split or no vote | For | Against * |
| Jackson National funds | For | No report | Against * |
| Northern Trust and FlexShares | Split or no vote | For | Against * |
| T. Rowe Price | For | For | For |
| Voya | Split or no vote | For | Against * |
| Victory Capital | For | No report | For |
| BNY Mellon | Split or no vote | For | Against * |
| Capital Group and American Funds | For | For | For |
| Pacific Life funds | For | For | Against * |
| AllianceBernstein | For | For | Abstain or withhold * |
| Hartford Funds | For | No report | For |
| PIMCO | Split or no vote | For | Against * |
| Lord Abbett | For | For | For |
| Dodge & Cox | For | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Jiangsu Hengrui Pharmaceuticals Co., Ltd. meeting?
71 Form N-PX filers reported votes at the meeting of 16 Apr 2026. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Jiangsu Hengrui Pharmaceuticals Co., Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Jiangsu Hengrui Pharmaceuticals Co., Ltd. with a meeting date within three days of 16 Apr 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.